About us

ABOUT CellSafe

Leader in Biopharmaceutical
Safety Evaluation, CellSafe

Leading biosafety testing in the field of biotech products
including biosimilars, vaccines, advanced biopharmaceuticals,
CellSafe has committed itself to the research and development to
ensure the safety and quality control of next-generation
biopharmaceuticals by implementing its innovative technology.
It has become the first company in Asia to have developed
Mycoplasma qPCR detection and removal kits.

Technology Vision

We drive innovation in biotechnology
through advanced technology
and a rigorous quality system.


Quality Management

CellSafe produces the products that meet the global standards through stringent quality management. All the products are manufactured in GMP-grade facility and strictly adhere to the ISO 13485 quality system.

Technology Innovation

CellSafe strives for continuous growth alongside the advancement of next-generation biopharmaceuticals through ongoing technological innovation. Leveraging its exceptional technical expertise, CellSafe will develop the solutions that can save users' time and enhance their productivity.


CellSafe always empathizes with customers and considers from their perspective and contemplates what they fundamentally need to provide solutions to them.

Since 2009

CellSafe's 10 Years of Pioneering a New Path,
A Future of Even More
Astonishing Growth and Innovation

Greetings from CEO

KEEP Your Cells Safe

CellSafe Co., Ltd. supplies molecular diagnostic products and technologies
which are essential to biosafety testing of biopharmaceuticals
(advanced biopharmaceuticals, vaccines, and biosimilars)
including Mycoplasma, adventitious viral agents, host residual DNA,
and replicable viruses to numerous biopharmaceutical companies home and abroad.

We will continue to grow into a world-class company by developing the products for
clinical diagnostics, innovative biomedicine materials, and their relevant products.

We’d like to extend our deep gratitude to all the customers for their support and will
contribute to the advancement of advanced biopharmaceuticals
through continuous innovation with the best technology and products.

Thank you.


CEO Han Jae Jin

Contact us

Go Top